Loading stock data…
EUDA
$15.84+0.38 (+2.46%)
After Hours$15.50-0.34 (-2.15%)· Last close Jun 9
EUDA Health Holdings Limited engages in the provision of non-invasive healthcare services primarily in Singapore, Malaysia, and China.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
EUDA Health Holdings Limited in the Real Estate sector is trading at $15.84 with a market capitalization of $47M. Wall Street consensus targets $55.00 (1 analysts), implying a +247.2% move over the next 12 months. The stock is currently near its 52-week low of $5.26, remaining 49.5% below its 200-day moving average. On fundamentals, Piotroski 5/9 shows mixed financial quality, Altman Z in the distress zone. Risk note: MACD remains below its signal line. The Whystock Score of 60/100 suggests a balanced risk-reward profile.
Ecosystem Influences
Sell-side targets imply +247.2% upside over 12 months
Long-term trend bearish (price vs 200-day SMA)
Macro-economic sensitivity to interest rate and inflation shifts
Loading Financials...
Peer Comparison
Whystock Valuation Model
Anchored to each ticker's own 5-year median trailing P/E, tilted by current ROE and growth. Fair P/E = own median P/E + (ROE × 10) + (max(revenue growth, earnings growth) × 15), capped at ±30% around the historical anchor. Fair Value = (Current Price ÷ Trailing P/E) × Fair P/E. Premium compounders like COST/MSFT are judged against their own multi-year norm rather than a sector median. Falls back to the sector-anchored formula (Tech ≈ 28, Comm Services ≈ 24, Utilities ≈ 18, Financials ≈ 14, etc.) for recent IPOs and tickers with insufficient history (< 24 monthly samples). Result is a normalised multiple gauge — not a price target.
Current Price$15.84
Potential Downside
0%
Whystock Fair Value$15.84
Price
UndervaluedFair ValueOvervalued
Simplified model based on P/E and ROE. Not a substitute for full valuation analysis. Data may be delayed. See our Terms.
Analyst Consensus1 analysts
Mean target$55.00+247.2%
Range$55.00 – $55.00
Fundamentals
EUDA Health Holdings Limited engages in the provision of non-invasive healthcare services primarily in Singapore, Malaysia, and China. It offers bioenergy cabin therapy packages; stem cell therapy services through third-party treatment centers; and h...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$47.43M
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
-
Beta
Defensive asset. Lower volatility than the S&P 500.
0.64
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROE
Average efficiency. Growth may require heavy reinvestment.
-
Volume
Today's trading volume
1,751
Recent News
EUDA Health price target lowered to $2.75 from $6 at Greenridge
Greenridge analyst William Gregozeski lowered the firm’s price target on EUDA Health (EUDA) to $2.75 from $6 and keeps a Buy rating on the shares. The firm updated its model for a reduction of Helixe bottles sold in 2026, decreasing to 50,000 from 105,000, which reduced its revenue estimate to $27.23M from $43.05M. It also added in the 12.5M shares that were issued in late February, which had a dilutive effect on its EPS estimates, the analyst tells investors.Claim 70% Off TipRanks PremiumUnlock
Top Midday Gainers
Hycroft Mining (HYMC) shares gained after the company said Monday its latest drilling program confir
Top Midday Decliners
EUDA Health (EUDA) said Monday that it is integrating the QB utility token into its digital health a
EUDA Health Holdings Limited (NASDAQ:EUDA) stock most popular amongst retail investors who own 47%, while private companies hold 26%
Key Insights The considerable ownership by retail investors in EUDA Health Holdings indicates that they collectively...